Quality Provider of Generics and Finished Dosage Formulations
See the latest news from our parent company Jubilant Pharma by using the below-mentioned link:
Jubilant Pharma announces the development of a novel oral formulation of Remdesivir with successful completion..
We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.